``

PHILIPS

PHILIPS MEDICAL SYSTEMS NEDERLAND BV (PMS)

Philips is a global health technology company focused on improving people’s health and well-being through meaningful innovation across the healthcare continuum. Within Philips, the Innovation & Design organization brings together expertise in technology, design, and clinical domains to develop new solutions. The Data Science & AI team contributes by delivering end-to-end AI capabilities and scalable solutions across the business, including applications such as clinical decision support, predictive maintenance, and generative AI. These solutions are developed to be secure, compliant, and responsible by design, and are applied across clinical, operational, and customer domains.

Contribution to PreciseOnco

PMS leads Work Package 1 – Data Collection and Annotation, contributing to the development of a Spectral CT and CBT database while ensuring full compliance with regulatory requirements.

Team

Mathias Simon

Matthias Simon is an experimental physicist with a PhD in physics. He joined Philips in 1998 as a Research Scientist in Aachen, Germany, working on X-ray conversion materials, detectors, and imaging physics.
 
In 2011, he became a Senior Scientist at Philips Research in Eindhoven, where he explored thin‑film organic electronics for X‑ray detection in collaboration with external research institutes. His expertise expanded to diagnostic and interventional X‑ray and CT systems, leading projects on dual‑energy and spectral X‑ray concepts. From 2018 to 2021, he contributed to a European public‑private partnership on stroke imaging using dual‑energy cone‑beam CT.
 
In 2024, he joined Philips IGT Systems Front‑End Innovation in Best, focusing on advanced CBCT development for neuro and oncology applications.

Nishant Singh

Nishant Singh is an R&D Engineer in the X‑ray Components department within the Image Chain cluster of Image Guided Therapy (IGT) systems at Philips Medical Systems in Best, the Netherlands.
 
He holds a Master’s degree in Electrical Engineering with a specialization in signal processing and communication systems and has over eleven years of experience developing advanced medical imaging technologies at Philips, ranging from diagnostic X‑ray to image‑guided therapy systems. His expertise focuses on algorithm development for X‑ray cone‑beam imaging, particularly scatter mitigation and reconstruction quality improvement. He has extensive experience with anti‑scatter grids, software‑based scatter correction, and mathematical modeling, combining strong theoretical foundations with hands‑on laboratory validation.
 
In the PreciseOnco IHI project, he contributes to Work Package 2, advancing dual‑layer detector–based spectral cone‑beam imaging for abdominal applications.

Julisca Cesar

Julisca Cesar is a Senior Clinical Scientist in Interventional Oncology within the Image Guided Therapy Systems division at Philips. She works at the intersection of clinical practice and scientific innovation, collaborating closely with clinicians and engineers to advance minimally invasive cancer treatments.
 
Her focus includes improving imaging technologies and planning and navigation software to enhance patient outcomes. Julisca holds a Research Master’s degree in Epidemiology from the University of Groningen, where she built a strong foundation in medical research and healthcare innovation. She previously completed an internship at the World Health Organization and began her career at Philips as an Associate Healthcare Consultant, later moving into clinical marketing and scientific research roles.
 
She actively contributes to educational initiatives and collaborative projects in interventional oncology.

Pedro Rodrigues

Pedro Rodrigues is a Clinical Scientist in Oncology at Philips, responsible for the clinical roadmap of IntelliSpace Portal Advanced Visualization solutions in Oncology and General Radiology.
 
With over 15 years of experience in diagnostic imaging and image‑guided therapies, he works at the intersection of clinical needs, artificial intelligence, and product strategy. His focus is on translating emerging technologies, particularly AI and deep learning, into validated, regulatory‑compliant clinical solutions. Pedro leads co‑creation with academic and clinical partners, supports FDA 510(k) and EU MDR evidence generation, and shapes innovation pipelines.
 
His background spans nuclear medicine (PET/CT), MR‑HIFU, radiotherapy, and integrated diagnostics. He combines technical expertise in system validation and imaging workflows with strong regulatory and market‑shaping experience.

Olivier Tousignant

Olivier Tousignant is a Technologist in X‑ray Detectors at Philips ICC X‑ray Components, with over 25 years of experience in X‑ray detector system design, innovation, and product introduction.
 
He has deep expertise across a broad range of detection technologies, including PCCT, CT, CBCT, radiography, mammography, nuclear medicine, dental applications, NDT, and spectral imaging. His work focuses primarily on performance characterization, reliability, and verification and validation. Throughout his career, Olivier has held diverse technical roles at leading companies in the field and has contributed to numerous commercially successful product designs.
 
His contributions have played a significant role in advancing X‑ray detector technologies and strengthening their market impact.

PHILIPS ELECTRONICS NEDERLAND BV (PEN)

The Medical Office at Philips provides clinical leadership, medical strategy, and scientific oversight across the health technology portfolio, ensuring innovations are clinically relevant and evidence based. Within this organization, the Public‑Private Partnerships (PPP) function drives strategic research and innovation initiatives focused on translational healthcare technologies and clinical value.
Operating at the intersection of clinical practice, research, and technology, the PPP team shapes innovation roadmaps, supports evidence generation, and enables integration of emerging technologies into care workflows. It fosters collaborations with academic, clinical, and industry partners, particularly within European programmes such as Horizon Europe and the Innovative Health Initiative, to translate research into scalable, clinically validated solutions.

Contribution to PreciseOnco

PEN serves as coordinator, leading the Work package 7 – Project Management. Through its expertise in clinical strategy, innovation management, and collaborative research implementation, the Philips Medical Office Public-Private Partnerships team strengthens the project’s capacity to deliver clinically relevant, scalable, and impactful solutions for precision oncology, contributing to improved patient outcomes and more efficient healthcare delivery.
PEN is an associated partner in PreciseOnco.

Team

Boris De Ruyter

Boris De Ruyter is the PreciseOnco project leader.
 
He is a theoretical and experimental psychologist with a PhD in Industrial Design Engineering. He spent 28 years as a Principal Scientist at Philips Research in Eindhoven, leading multidisciplinary research at the intersection of technology, human behaviour, and healthcare innovation.
His work focused on translating emerging technologies into robust, evidence‑based solutions, combining theory‑driven models with quantitative empirical research and advanced statistical methods. He has a strong publication record and extensive experience supervising doctoral research and contributing to publicly funded programmes.
 
Since 2023, Boris has been part of Philips Innovation & Design, where he supports business teams in shaping innovation strategies and designing large‑scale quantitative product research and validation studies, drawing on expertise in behavioural science and research methodology.

Burcu Gumuscu, Ph.D.

Burcu Gumuscu, Ph.D., is a Project Coordinator at Philips specializing in European research and innovation programmes in health technology, with a focus on precision medicine, medical imaging, and translational clinical research.
 
She works at the intersection of industry, academia, and healthcare, supporting the design and execution of large‑scale collaborative projects that translate emerging technologies into clinical practice. Her expertise includes strategic proposal development, project architecture design, impact pathway definition, and governance of complex public‑private partnerships within Horizon Europe, the Innovative Health Initiative, and Dutch national programmes.
 
Burcu has an academic background in biomedical engineering and particular interests in innovation management, artificial intelligence in healthcare, and integrating advanced technologies into clinical workflows to deliver scalable, patient‑centred solutions.

PHILIPS FRANCE (PFC)

Philips France is the French subsidiary of Koninklijke Philips N.V., a global health technology leader focused on improving health and well‑being through innovation. Headquartered in Suresnes, with additional sites across France, it operates across Diagnosis & Treatment, Connected Care, and Personal Health. Philips France delivers advanced medical imaging, patient monitoring, health informatics, and consumer health solutions, with a strong legacy in radiology and medical imaging. The organization supports hospitals, clinics, and consumers while contributing to Philips’ mission to improve 2.5 billion lives annually by 2030 through innovation, research, and certified healthcare training.

Contribution to PreciseOnco

Philips France will support the French clinical partners, HCL and APHP, in running the clinical studies, bringing technical knowledge on the imaging systems, providing advanced training for the clinical staff, contributing to protocol optimization, data collection and analysis, and publications.
Employees from Philips France will also lead or contribute to different work packages: WP1 for data management; WP2 for data collection for algorithm development and evaluation with the clinical partners; WP3 for optimizing workflow and image acquisition protocols for interventional oncology procedures; WP4 for developing and validating specific biomarkers based on spectral imaging for treatment endpoint determination and follow-up.

Team

Philippe Coulon

Philippe Coulon is Director of CT Clinical Science Radiology at Philips CT Business Unit. Holding an engineering degree in physics and chemistry and a PhD in physics, Philippe has over 20 years experience in CT technologies and applications, including spectral CT and interventional CT.

Nina Bufi

Nina Bufi is an Innovation Partnership Lead at Philips, where she structures, steers, and scales enterprise level innovation partnerships across multiple business units and clinical domains.

She owns partnership strategy, governance, and execution, acting as the central orchestrator between internal teams and external partners to translate shared ambitions into concrete, measurable innovation outcomes. An engineer with a PhD and over 10 years of experience in healthcare innovation, Nina has held roles across startups, large corporates, and government entities, giving her a strong track record in managing complex interfaces and multi stakeholder ecosystems.

She is recognized for her ability to align diverse perspectives, build trusted relationships, and drive high impact, first of a kind innovation initiatives from strategy to execution.

Alexia Vidal

Alexia Vidal is a Clinical Development Scientist at Philips, where she drives strategic innovation initiatives and cultivates a strong and engaged Key Opinion Leader network in Image Guided Therapy across France.


Trained as an engineer with a PhD in neurosciences and over six years of experience in Healthcare Medical Affairs across startups and large organizations, she demonstrates strong expertise in translating Research & Development into clinically relevant and impactful innovations for end users.

Jean-Michel Rouet

Jean-Michel Rouet is a Senior Data Scientist at Philips France, where he has been conducting research since 2000 on medical image post-processing algorithms.

He holds an engineering degree and a PhD in medical image processing. His current work focuses on computer vision and AI-based methods for quantitative medical image analysis, with research contributions spanning cardiovascular, chest, and liver imaging in CT, MR and Ultrasound.

PHILIPS GmbH (PGE)

The Philips GmbH with headquarter in Hamburg, Germany is the base for important industrial activities and German medical research. In the Hanseatic city, the company develops and produces X-ray tubes and generators, while the manufacturing and development center for medical technology also produces X-ray systems. German medical research, Philips Innovative Technologies, with its main research areas of medical imaging systems, image formation and image analysis, is also based on the Philips Campus in Hamburg. 60 scientists from the fields of physics, mathematics, electrical engineering, and computer science are working on future challenges in global healthcare. Innovative technology concepts for computed tomography, magnetic resonance imaging, ultrasound, diagnostic and interventional X-ray and artificial intelligence in health technology are being researched in collaboration with universities and clinics.

Contribution to PreciseOnco

The main role of PGE in the project is in Work package 2 and more specifically in Task 2.3 Spectral CT image quality improvement and dose reduction. It is about Image formation algorithm development, testing and evaluation for image noise reduction, spatial resolution enhancement and artifact removal for diagnostic conventional and spectral CT.

Team

Michael Grass

Michael Grass is Director of CT Clinical Science Radiology at Philips CT Business Unit. Holding an engineering degree in physics and chemistry and a PhD in physics, Philippe has over 20 years experience in CT technologies and applications, including spectral CT and interventional CT.

PHILIPS BEGIUM COMMERCIAL (PBC)

Philips Belgium Commercial is the Belgian commercial entity of Koninklijke Philips N.V., operating primarily in the healthcare and pharmaceutical wholesale sector. The company is headquartered at Burgemeester Etienne Demunterlaan 1, 1090 Jette (Brussels). It was established on 25 June 2015.

Its core business activity is the wholesale distribution of pharmaceutical and medical products. Overall, Philips Belgium Commercial plays a central role in Philips’ Benelux commercial operations, combining structured distribution, regulatory compliance, and marketplace support to deliver advanced healthcare products efficiently across Belgium. Philips Belgium Commercial is supporting hospitals, clinics, pharmacies, and medical professionals with access to high quality equipment, devices, and associated medical supplies.

Contribution to PreciseOnco

Alain Vlassenbroek is member of the CT/AMI Clinical Science Group, which is part of the CT Business Unit. Philips Belgium Commercial is Hosting Business Unit employees, based in Belgium.

Team

Dr. Alain Vlassenbroek

Dr. Alain Vlassenbroek is clinical scientist at Philips, holding a Master degree in Science (Physics) and a PhD in Physics in the feld of Nuclear Magnetic Resonance, from “Université Libre de Bruxelles” (ULB). Has 31-year experience in CT technologies and applications, including spectral CT.